-- GRAS Notification Expands Application Options for Nutritional Oil Rich in Gamma-linolenic acid (GLA) for Uses in Nutritional Beverages and Medical Foods --

 

DAVIS, Calif.  -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted Arcadia’s conclusion that its SONOVA® GLA safflower oil is “generally recognized as safe” (GRAS) for use in nutritional beverages and medical foods.

 

Arcadia produces GLA safflower nutritional oils with high concentrations of gamma-linolenic acid (GLA). These oils are marketed by Arcadia under the SONOVA® brand and are currently used in nutritional supplement products. GLA is a nutritionally important omega-6 fatty acid that helps support the body’s anti-inflammatory response and is especially useful for managing weight, improving skin health and maintaining hormonal balance for women. When used in combination with the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), GLA has been shown to support heart and eye health.

HACKENSACK, N.J., Nov. 29, 2016  -- Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the second quarter ended October  31, 2016.

 

Second Quarter and Recent Business Highlights:

Record quarterly revenue of $4.5 million;

Second quarter revenue growth of 50%; 59% growth in TOS segment;

Reaffirms annual revenue guidance for current fiscal year of $16 - 18 million;

Quarterly cash burn reduced to less than $150,000 with $4.3 million of cash at the end of the quarter;

QINGDAO, China and ROCKVILLE, Md., Nov. 17, 2016 -- Synutra International, Inc. (SYUT), ("Synutra" or the "Company"), which owns subsidiaries in China that produce, distribute and sell nutritional products for infants, children and adults, today announced it has entered into an Agreement and Plan of Merger (the "Merger Agreement") with Beams Power Investment Limited, a company with limited liability incorporated under the laws of the British Virgin Islands ("Parent"), and Beams Power Merger Sub Limited, a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger"). Parent currently beneficially owns approximately 63.5% of the Company's outstanding shares of common stock, $0.0001 par value per share (the "Company Common Stock"). Ms. Xiuqing Meng, spouse of Mr. Liang Zhang, is the sole shareholder of Parent. Mr. Liang Zhang is the chairman and chief executive officer of the Company.

PORTLAND, Ore. & PALO ALTO, Calif.-- Lattice Semiconductor Corporation (LSCC) (“Lattice” or the “Company”) and Canyon Bridge Capital Partners, Inc. (“Canyon Bridge”) today announced that the Company and Canyon Bridge Acquisition Company, Inc. (“Parent”), an affiliate of Canyon Bridge, have signed a definitive agreement under which Parent will acquire all outstanding shares of Lattice for approximately $1.3 billion inclusive of Lattice’s net debt, or $8.30 per share in cash. This represents a 30% premium to Lattice’s last trade price on November 2, 2016, the last trading day prior to announcement.

 

Darin G. Billerbeck, President and Chief Executive Officer of Lattice, commented, “We are pleased to announce the transaction today with Canyon Bridge, which will unlock tremendous value for shareholders. This transaction is the culmination of an extensive review process with our Board, financial and legal advisers, and it delivers certain and immediate cash value to shareholders while reducing our execution risk.